Matteo Lai was part of a panel at DPharm in Boston this year, it was called working together to accelerate the adoption of digital biomarkers in clinical trials.
The physIQ monitoring platform will be used to evaluate an inhaled treatment, developed by InCarda, that is intended to treat atrial fibrillation patients.
Taking place July 20, the Decentralized Trial Technology webinar will share insights and experiences from a group of knowledgeable virtual trial experts.
A study out of Israel's Sheba Medical Center found wearables used to monitor patients can provide early warnings of deterioration, as well as false alarms.
Electronic health record solutions provider Athenahealth has partnered with Withings Health Solutions to put the RPM tech into place for clinical and care use.
Withings Health Solutions' new remote patient monitoring (RPM) system seeks to tackle complexities identified after the launch of its first offering in the space.
According to a leader from the health engagement solutions firm, intelligent use of technology tools can add patient-centricity and realism to a study.
The health data specialist and pharma firm are partnering on solutions around remote collection of digital data for detection and monitoring of treatments.
The companies are joining on a hybrid clinical trial to test a potential COVID-19 treatment, featuring an ambitious remote patient monitoring strategy.
A leader from the trial solutions provider discusses how the COVID-19 pandemic has accelerated the already growing interest in remote patient monitoring.
The Verisense Pulse+ can measure heart rate, oxygen saturation, emotional responses, and activity and sleep levels of at-home clinical trial participants.
The technology is designed to streamline and simplify integration, data collection and analysis, and digital biomarker discovery with wearable sensors.
The Medical Data Platform, an RPM solution from VivaLNK, handles clinical trials, cardiac monitoring, remote and in-patient monitoring and other tasks.
VivaLNK’s wearable sensor platform – currently being used in a clinical trial to remotely monitor patients – integrates hardware, connectivity, and application software, taking an "uncommon" approach in the medical technology space, says CEO.